Australia's most trusted
source of pharma news
Friday, 14 March 2025
Posted 6 May 2024 AM
Recent back-to-back resignation announcements has resulted in top roles opening up across industry with the hunt on for at least five company leaders in Australia underway.
First to go was Chiesi's Chris Rossidis, who brought Australia's first medicinal cannabinoid product to Australia for rare types of childhood onset epilepsy. He retired at the end of March after a long career in pharma including stints at CSL, GSK and Eli Lilly.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.